Optimizing R/R CLL Treatment: Therapy Sequencing and Supportive Care Strategies - Episode 7
Application of Pirtobrutinib in R/R CLL: Expert Perspectives
Panelists discuss how utilizing pirtobrutinib in clinical practice, focusing on its application in patients who have developed resistance or intolerance to prior BTK inhibitors, as well as in those who have shown resistance to both BTK and BCL-2 inhibitors in chronic lymphocytic leukemia treatment.
Video content above is prompted by the following:
- How are you currently using pirtobrutinib in your clinical practice?
- Resistance or intolerance to prior BTKi?
- Resistance to both BTKi and BCL-2 inhibitor?
Related Content:
